HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Exploring AI-Based Manufacturing, Shelf Optimization With Retailers: ‘Supply Chain 3.0’ Update

Executive Summary

Automation through artificial intelligence, which saw significant progress during the COVID-19 pandemic amid labor shortages, is an area of focus for P&G as it continues work under its Supply Chain 3.0 initiative. The firm also is providing data analysis to retailers to encourage shelf simplification, company leadership says.

You may also be interested in...



Whether Higher Sales Or Lower Volumes, Price Increases Make Presence Known For P&G And C&D

Both health, wellness and beauty product marketers on report increased prices helped drive revenue growth during April-June period while also factoring in lower sales volumes.

P&G’s Answer To Logistics Challenges In COVID Era: ‘Supply Chain 3.0’

P&G will provide additional detail at its November Investor Day, but says Supply Chain 3.0 is an adaptation to the new normal that will unlock efficiencies and enable reinvestment in brands.

Arcaea Resurrects Extinct Flowers With First Fragrances Under Future Society Brand; Cosmetics News

Coty and English footballer David Beckham announce a collection of eau de parfums rolling out to US retailers nationwide in January following a debut in JCPenney. Arcaea introduces biotech-based scents capturing the essence of extinct flowers, and Procter & Gamble’s Mielle hair-care brand launches its first ad campaign. More product launch and marketing news.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153995

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel